Literature DB >> 12759460

Complement C5a receptor-mediated signaling may be involved in neurodegeneration in Alzheimer's disease.

Imre Farkas1, Mitsuo Takahashi, Atsuo Fukuda, Naoki Yamamoto, Hiroyasu Akatsu, Lajos Baranyi, Hisashi Tateyama, Takayuki Yamamoto, Noriko Okada, Hidechika Okada.   

Abstract

In our earlier results, we demonstrated that cells expressing the complement C5aR are vulnerable since abnormal activation of C5aR caused apoptosis of these cells. In this study, we demonstrate that activation of C5aR by antisense homology box (AHB) peptides synthesized in multiple antigenic peptide form and representing putative interaction sites of the C5a/C5aR evoked calcium influx in TGW neuroblastoma cells. Dose-dependent inhibition of the response was found when the cells were pretreated with C5a, suggesting that C5aR was involved in this process. In addition, pretreatment with monomeric forms of the AHB peptides resulted in attenuation of the calcium signals, supporting the idea of the role of C5aR in this process. Cells of a neuron-rich primary culture and pyramidal cells of rat brain slices also responded to the AHB peptide activation with an increase in the intracellular calcium level, showing that calcium metabolism might be affected in these cells. TUNEL staining demonstrated that C5aR-mediated apoptosis could be induced both in cells of the primary culture as well as in cortical pyramidal neurons of the rat brain. In addition, we investigated expression of C5aR in the hippocampal and cortical neurons of human brains of healthy and demented patients using two anti-human C5aR Abs. Pyramidal cells of the hippocampus and cortex and granular cells of the hippocampus were immunopositive on staining. Although staining was also positive in the vascular dementia brain, it disappeared in the brain with Alzheimer's disease. These results provide further support that C5aR may be involved in neurodegeneration.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 12759460     DOI: 10.4049/jimmunol.170.11.5764

Source DB:  PubMed          Journal:  J Immunol        ISSN: 0022-1767            Impact factor:   5.422


  20 in total

1.  Protective effect of carbamazepine on kainic acid-induced neuronal cell death through activation of signal transducer and activator of transcription-3.

Authors:  Hae Jeong Park; Su Kang Kim; Joo-Ho Chung; Jong Woo Kim
Journal:  J Mol Neurosci       Date:  2012-07-08       Impact factor: 3.444

2.  Potential beneficial effects of low molecular weight heparin on cognitive impairment in elderly patients on haemodialysis.

Authors:  Milenka Sain; Vedran Kovacic; Josipa Radic; Dragan Ljutic; Ivo Jelicic
Journal:  Drugs Aging       Date:  2012-01-01       Impact factor: 3.923

Review 3.  The role of the anaphylatoxins in health and disease.

Authors:  Andreas Klos; Andrea J Tenner; Kay-Ole Johswich; Rahasson R Ager; Edimara S Reis; Jörg Köhl
Journal:  Mol Immunol       Date:  2009-05-28       Impact factor: 4.407

Review 4.  Neuroprotection in stroke by complement inhibition and immunoglobulin therapy.

Authors:  T V Arumugam; T M Woodruff; J D Lathia; P K Selvaraj; M P Mattson; S M Taylor
Journal:  Neuroscience       Date:  2008-07-12       Impact factor: 3.590

5.  Exploratory data from complete genomes of familial alzheimer disease age-at-onset outliers.

Authors:  Matthew A Lalli; Gloria Garcia; Lucia Madrigal; Mauricio Arcos-Burgos; Mary Luz Arcila; Kenneth S Kosik; Francisco Lopera
Journal:  Hum Mutat       Date:  2012-08-10       Impact factor: 4.878

6.  Gangliosides play pivotal roles in the regulation of complement systems and in the maintenance of integrity in nerve tissues.

Authors:  Yuhsuke Ohmi; Orie Tajima; Yuki Ohkawa; Atsushi Mori; Yasuo Sugiura; Keiko Furukawa; Koichi Furukawa
Journal:  Proc Natl Acad Sci U S A       Date:  2009-12-11       Impact factor: 11.205

7.  The role of the complement system and the activation fragment C5a in the central nervous system.

Authors:  Trent M Woodruff; Rahasson R Ager; Andrea J Tenner; Peter G Noakes; Stephen M Taylor
Journal:  Neuromolecular Med       Date:  2009-09-11       Impact factor: 3.843

8.  Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease.

Authors:  Jun Zhou; Maria I Fonseca; Karntipa Pisalyaput; Andrea J Tenner
Journal:  J Neurochem       Date:  2008-07-09       Impact factor: 5.372

9.  C5a alters blood-brain barrier integrity in experimental lupus.

Authors:  Alexander Jacob; Bradley Hack; Eddie Chiang; Joe G N Garcia; Richard J Quigg; Jessy J Alexander
Journal:  FASEB J       Date:  2010-01-11       Impact factor: 5.191

10.  The C5a anaphylatoxin receptor CD88 is expressed in presynaptic terminals of hippocampal mossy fibres.

Authors:  James W Crane; Gilang P Baiquni; Robert Kp Sullivan; John D Lee; Pankaj Sah; Stephen M Taylor; Peter G Noakes; Trent M Woodruff
Journal:  J Neuroinflammation       Date:  2009-11-16       Impact factor: 8.322

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.